top of page
Judy pic circle crop (5).png


Advocating on behalf of patients and survivors to improve treatment and quality of life is the passion of our Founder, Judy Fitzgerald. Updates to speaking engagements, educational forums, government seminars and vaccine progress will be noted here. 

Judy's Work

Screenshot 2024-01-11 105611.png




January 17, 2024

TOUCH Breast Cancer

Alliance Live Show

What's The Real Deal On The TNBC Vaccine?

Black women with TNBC are 28% more likely to die than white women who received the same diagnosis. 40% of TNBC patients are under the age of 40. Breast density is more strongly associated with TNBC than other subtypes. TNBC is more likely to come back than other breast cancer types and subtypes--about 40% of people with stage 1 to 3 TNBC will experience a recurrence after treatment. TNBC is the most common type of breast cancer in patients who have BRCA1 mutations. Though some progress is being made, TNBC has the least treatment options.

Judy appeared on The Doctor Is In with Jennifer Davis, the first patient in the world to receive the vaccine. She opted to receive the vaccine after completing her treatment for TNBC to prevent recurrence.  Dr. Justin Johnson also joined us to explain the vaccine.  Our goal was to recruit women of color for the trial.

Screenshot 2024-01-18 071831.png
Screenshot 2024-01-04 190213.png
Screenshot 2024-01-08 122921.png

December 3-9, 2023

San Antonio Breast Cancer Syposium

The San Antonio Breast Cancer Conference is a leading event in the field of breast cancer research and treatment. It brings together experts from around the world to share the latest findings and advancements in the fight against breast. Attendees can expect to gain valuable insights and knowledge that can help improve patient outcomes and ultimately lead to a cure for this devastating disease. Judy, Dr. Justin Johnson and Dr. Thomas Budd presented the latest results on the vaccine trial documenting the immune response thus far from patients. The International conference which is held yearly in San Antonio focusses on the latest paradigm changes in treatment and results from ongoing clinical trials.  In addition, it's an invaluable opportunity to network with fellow advocates, researchers, government officials and policy makers.

November 15, 2023

Washington, DC

Friends of Cancer Research Annual Meeting is an event that brings together leading experts in the field of cancer research to discuss the latest advancements and breakthroughs. This year's meeting promises to be an exciting informative event, with a focus on collaboration and innovation. Join us as we work together to find ways to prevent, diagnose, and treat cancer.

September  4-6, 2023

Cochrane London Colloquium

The Cochrane London Symposium is an annual event that brings together healthcare professionals, researchers, and policymakers to discuss the latest developments in evidence-based medicine. With a focus on improving patient outcomes through the use of high-quality research, the symposium is a must-attend event for anyone interested in advancing the field of healthcare. Judy received a scholarship from Cochrane and attended as an advocate and document reviewer.

October 16

Survivor Summitt 

Debbie Wasserman Schultz hosted the Survivor Summit, an event aimed at empowering survivors of sexual assault and domestic violence. The summit brought together survivors, advocates, and lawmakers to discuss ways to improve support and resources for survivors. Schultz's efforts to raise awareness and promote change are commendable.

Screenshot 2024-01-08 122715.png


AACR Orlando Meeting

Poster presentation with Dr. Budd.  The highlight was meeting Jennifer Davis, the first recipient of the vaccine. The AACR Meeting in Orlando is a must-attend event for anyone in the field of cancer research. With top-notch speakers and cutting-edge research presentations, attendees are sure to leave with new insights and connections. Don't miss out on this exciting opportunity to advance your knowledge and career in the fight against cancer

bottom of page